| 789878 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy |
2022-01-01 |
10.1136/jitc-2021-003133 |
Shi Jiawei, Liu Junwei, Tu Xiaoxuan, Li Bin, Tong Zhou, Wang Tian, Zheng Yi, Shi Hongyu, Zeng Xun, Chen Wei, Yin Weiwei, Fang Weijia |
| 789877 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
CD4 T cell-intrinsic STING signaling controls the differentiation and effector functions of TH1 and TH9 cells |
2022-01-01 |
10.1136/jitc-2021-003459 |
Benoit-Lizon Isis, Jacquin Elise, Rivera Vargas Thaiz, Richard Corentin, Roussey Aurélie, Dal Zuffo Ludivine, Martin Tiffany, Melis Andréa, Vinokurova Daria, Shahoei Sayyed Hamed, Baeza Garcia Alvaro, Pignol Cassandre, Giorgiutti Stéphane, Carapito Raphaël, Boidot Romain, Végran Frédérique, Flavell Richard A, Ryffel Bernhard, Nelson Eric R, Soulas-Sprauel Pauline, Lawrence Toby, Apetoh Lionel |
| 789876 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer |
2022-01-01 |
10.1136/jitc-2021-004033 |
Chun Brie, Pucilowska Joanna, Chang ShuChing, Kim Isaac, Nikitin Benjamin, Koguchi Yoshinobu, Redmond William L, Bernard Brady, Rajamanickam Venkatesh, Polaske Nathan, Fields Paul A, Conrad Valerie, Schmidt Mark, Urba Walter J, Conlin Alison K, McArthur Heather L, Page David B |
| 789875 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Intermediate monocytes induced by IFN-γ inhibit cancer metastasis by promoting NK cell activation through FOXO1 and interleukin-27 |
2022-01-01 |
10.1136/jitc-2021-003539 |
Wang Rikang, Bao Weili, Pal Mouli, Liu Yunfeng, Yazdanbakhsh Karina, Zhong Hui |
| 789874 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10+ advanced non-small cell lung cancer |
2022-01-01 |
10.1136/jitc-2021-003581 |
Blumenschein George R, Devarakonda Siddhartha, Johnson Melissa, Moreno Victor, Gainor Justin, Edelman Martin J, Heymach John V, Govindan Ramaswamy, Bachier Carlos, Doger de Spéville Bernard, Frigault Matthew J, Olszanski Anthony J, Lam Vincent K, Hyland Natalie, Navenot Jean-Marc, Fayngerts Svetlana, Wolchinsky Zohar, Broad Robyn, Batrakou Dzmitry, Pentony Melissa M, Sanderson Joseph P, Gerry Andrew, Marks Diane, Bai Jane, Holdich Tom, Norry Elliot, Fracasso Paula M |
| 789873 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Lower baseline autoantibody levels are associated with immune-related adverse events from immune checkpoint inhibition |
2022-01-01 |
10.1136/jitc-2021-004008 |
Ghosh Nilasha, Postow Michael, Zhu Chengsong, Jannat-Khah Deanna, Li Quan-Zhen, Vitone Greg, Chan Karmela K, Bass Anne R |
| 789872 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Potential therapies for immune-related adverse events associated with immune checkpoint inhibition: from monoclonal antibodies to kinase inhibition |
2022-01-01 |
10.1136/jitc-2021-003551 |
Henderson Berg Meagan-Helen, del Rincón Sonia Victoria, Miller Wilson H |
| 789871 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16− subset |
2022-01-01 |
10.1136/jitc-2021-003385 |
Veneziani Irene, Alicata Claudia, Pelosi Andrea, Landolina Nadine, Ricci Biancamaria, D'Oria Valentina, Fagotti Anna, Scambia Giovanni, Moretta Lorenzo, Maggi Enrico |
| 789870 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells |
2022-01-01 |
10.1136/jitc-2021-003826 |
Tokatlian Talar, Asuelime Grace E, Mock Jee-Young, DiAndreth Breanna, Sharma Shruti, Toledo Warshaviak Dora, Daris Mark E, Bolanos Kristian, Luna Breanna L, Naradikian Martin S, Deshmukh Kiran, Hamburger Agnes E, Kamb Alexander |
| 789869 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell response in the syngeneic mouse model |
2022-01-01 |
10.1136/jitc-2021-003809 |
Wang Ruikun, Chen Jingru, Wang Wei, Zhao Zhuoqian, Wang Haoran, Liu Shiyu, Li Fan, Wan Yajuan, Yin Jie, Wang Rui, Li Yuanke, Zhang Cuizhu, Zhang Hongkai, Cao Youjia |
